The acetyltransferase HAT1 moderates the NF-κB response by regulating the transcription factor PLZF.

Nat Commun

1] Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, Victoria 3168, Australia [2] Department of Molecular and Translational Science, Monash University, Melbourne, Victoria 3168, Australia [3] Institute of Ageing Research, Hangzhou Normal University School of Medicine, 1378 Wenyi Road West, Hangzhou, Zhejiang 311121, China.

Published: April 2015

To date, the activities of protein kinases have formed the core of our understanding of cell signal transduction. Comprehension of the extent of protein acetylation has raised expectations that this alternate post-transcriptional modification will be shown to rival phosphorylation in its importance in mediating cellular responses. However, limited instances have been identified. Here we show that signalling from Toll-like or TNF-α receptors triggers the calcium/calmodulin-dependent protein kinase (CaMK2) to activate histone acetyltransferase-1 (HAT1), which then acetylates the transcriptional regulator PLZF. Acetylation of PLZF promotes the assembly of a repressor complex incorporating HDAC3 and the NF-κB p50 subunit that limits the NF-κB response. Accordingly, diminishing the activity of CaMK2, the expression levels of PLZF or HAT1, or mutating key residues that are covalently modified in PLZF and HAT1, curtails control of the production of inflammatory cytokines. These results identify a central role for acetylation in controlling the inflammatory NF-κB transcriptional programme.

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms7795DOI Listing

Publication Analysis

Top Keywords

nf-κb response
8
plzf hat1
8
plzf
5
acetyltransferase hat1
4
hat1 moderates
4
nf-κb
4
moderates nf-κb
4
response regulating
4
regulating transcription
4
transcription factor
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!